7-<i>tert</i>-Butyl-1,3-bis-(eth-oxy-meth-yl)pyrene. [PDF]
Moriguchi T, Sasaki M, Miyoshi N.
europepmc +1 more source
Tendencies in the association between fatigue and quality of life in terminally ill patients with cancer admitted to a palliative care unit. [PDF]
Matsuda M, Koyama Y, Seki N, Sakai S.
europepmc +1 more source
Crystal structure and Hirshfeld surface analysis of 3-acetyl-11-keto-β-boswellic acid. [PDF]
Dinesh B +5 more
europepmc +1 more source
Crystal structure and Hirshfeld surface analysis of saflufenacil. [PDF]
Liu J.
europepmc +1 more source
Crystal structure and Hirshfeld surface analysis of 1-(furan-2-yl)-2-(thio-phene-2-carbon-yl)-3-(thio-phen-2-yl)-2,3,3a,8a-tetra-hydro-cyclo-penta-[<i>a</i>]inden-8(1<i>H</i>)-one. [PDF]
Gezegen H +4 more
europepmc +1 more source
20-Oxa-penta-cyclo-[15.2.1.0<sup>2,16</sup>.0<sup>3,8</sup>.0<sup>10,15</sup>]icosa-2(16),3,5,7,10(15),11,13,18-octaen-9-one. [PDF]
Schollmeyer D, Detert H.
europepmc +1 more source
Synthesis and crystal structure of di-μ-chlorido-bis-[bis(2,6-di-methyl-pyrazine)-copper(I)] and di-μ-bromido-bis[bis(2,6-di-methyl-pyrazine)copper(I)]. [PDF]
Näther C.
europepmc +1 more source
Synthesis and structure of (<i>RS</i>)-6-hy-droxy-6-(2-oxoprop-yl)-1,10-phenanthrolin-5(6<i>H</i>)-one. [PDF]
Benlatreche T +3 more
europepmc +1 more source
2-[(2,5-Di-methyl-phen-yl)amino]-quinoline-3-carb-oxy-lic acid. [PDF]
Ji X, Long S.
europepmc +1 more source

